Cargando…
COVID-19 variants that escape vaccine immunity: Global and Indian context—are more vaccines needed?
The COVID-19 pandemic that emerged around December 2019 claimed millions of lives. For vaccine development, S protein on viral envelope that binds to ACE2 receptor on cells for entry was identified as vaccine candidate. S protein consists of Receptor Binding Motif (RBM) in the S1 subunit followed by...
Autores principales: | Deb, Bijayeeta, Vilvadrinath, Ramya, Goel, Suchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633907/ https://www.ncbi.nlm.nih.gov/pubmed/34857677 http://dx.doi.org/10.1007/s12038-021-00226-7 |
Ejemplares similares
-
Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials
por: Deb, Bijayeeta, et al.
Publicado: (2020) -
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022) -
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022) -
SARS-CoV-2 variants, immune escape, COVID-19 vaccine, and therapeutic strategies
por: Que, Haiying, et al.
Publicado: (2022) -
Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022)